Key result
Rivaroxaban resolves persistent biventricular thrombi in a peripartum cardiomyopathy patient after heparin and warfarin failure.
Why the study?
Does rivaroxaban resolve biventricular thrombi in a patient with peripartum cardiomyopathy refractory to heparin and warfarin?
Case Report (n=1)
No
Does rivaroxaban resolve biventricular thrombi in a patient with peripartum cardiomyopathy refractory to heparin and warfarin?
Rivaroxaban may be an effective treatment option for managing uncommon biventricular thrombi in patients with peripartum cardiomyopathy when standard anticoagulation fails.
Answers are grounded in this paper and cite their sources.
May support rivaroxaban in refractory biventricular thrombi with peripartum cardiomyopathy; hypothesis-generating and requires prospective confirmation.
Peripartum cardiomyopathy (PPCM) is a potential complication of pregnancy, described as left ventricular (LV) dysfunction (characterised as LV ejection fraction < 45%) occurring towards the end of pregnancy or in the months following delivery. Decreased LV contractility can lead to various complications, including the formation of an LV thrombus. We report the case involving a woman in her 20s with a history of PPCM, who developed biventricular thrombi with a rare mid-septal LV thrombus months after diagnosis. Despite initial treatment with heparin and warfarin, the thrombi persisted. A switch to rivaroxaban led to the resolution of both thrombi. This case underscores the importance of early anticoagulation in patients with PPCM and the potential role of rivaroxaban as a treatment option in managing uncommon thrombi in these patients.
No takes yet. Share an insight, caveat, or question.
Ziaullah et al. (2025) conducted a case report in Peripartum cardiomyopathy with biventricular thrombi (n=1). Rivaroxaban vs. Heparin and warfarin was evaluated on Resolution of thrombi. Switching to rivaroxaban led to the resolution of persistent biventricular thrombi in a patient with peripartum cardiomyopathy who failed initial treatment with heparin and warfarin.
Synapse has enriched 10 related papers. Consider them for comparative context: